103 related articles for article (PubMed ID: 9804912)
1. The frequency of illegitimate V(D)J recombinase-mediated mutations in children treated with etoposide-containing antileukemic therapy.
Fuscoe JC; Knapp GW; Hanley NM; Setzer RW; Sandlund JT; Pui CH; Relling MV
Mutat Res; 1998 Nov; 419(1-3):107-21. PubMed ID: 9804912
[TBL] [Abstract][Full Text] [Related]
2. A human lymphoid leukemia cell line with a V(D)J recombinase-mediated deletion of hprt.
Chen CL; Woo MH; Neale GA; Goorha RM; Fuscoe JC; Behm FG; Mathew S; Relling MV
Mutat Res; 1998 Jul; 403(1-2):113-25. PubMed ID: 9726012
[TBL] [Abstract][Full Text] [Related]
3. Quantification of illegitimate V(D)J recombinase-mediated mutations in lymphocytes of newborns and adults.
Scheerer JB; Xi L; Knapp GW; Setzer RW; Bigbee WL; Fuscoe JC
Mutat Res; 1999 Dec; 431(2):291-303. PubMed ID: 10635995
[TBL] [Abstract][Full Text] [Related]
4. Etoposide causes illegitimate V(D)J recombination in human lymphoid leukemic cells.
Chen CL; Fuscoe JC; Liu Q; Relling MV
Blood; 1996 Sep; 88(6):2210-8. PubMed ID: 8822941
[TBL] [Abstract][Full Text] [Related]
5. V(D)J recombinase-mediated HPRT mutations in peripheral blood lymphocytes of normal children.
Finette BA; Poseno T; Albertini RJ
Cancer Res; 1996 Mar; 56(6):1405-12. PubMed ID: 8640832
[TBL] [Abstract][Full Text] [Related]
6. Quantification of hprt gene deletions mediated by illegitimate V(D)J recombination in peripheral blood cells of humans.
Fuscoe JC; Vira LK; Collard DD; Moore MM
Environ Mol Mutagen; 1997; 29(1):28-35. PubMed ID: 9020304
[TBL] [Abstract][Full Text] [Related]
7. Alternative end-joining in follicular lymphomas' t(14;18) translocation.
Marculescu R; Le T; Böcskör S; Mitterbauer G; Chott A; Mannhalter C; Jaeger U; Nadel B
Leukemia; 2002 Jan; 16(1):120-6. PubMed ID: 11840271
[TBL] [Abstract][Full Text] [Related]
8. V(D)J recombinase-mediated deletion of the hprt gene in T-lymphocytes from adult humans.
Fuscoe JC; Zimmerman LJ; Harrington-Brock K; Burnette L; Moore MM; Nicklas JA; O'Neill JP; Albertini RJ
Mutat Res; 1992 Sep; 283(1):13-20. PubMed ID: 1380658
[TBL] [Abstract][Full Text] [Related]
9. The frequency of illegitimate TCRbeta/gamma gene recombination in human lymphocytes: influence of age, environmental exposure and cytostatic treatment, and correlation with frequencies of t(14;18) and hprt mutation.
Meydan D; Nilsson T; Törnblom M; Hagmar L; Hellgren D; Fuscoe JC; Lambert B
Mutat Res; 1999 Aug; 444(2):393-403. PubMed ID: 10521679
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the V(D)J recombination efficiency at lymphoid chromosomal translocation breakpoints.
Raghavan SC; Kirsch IR; Lieber MR
J Biol Chem; 2001 Aug; 276(31):29126-33. PubMed ID: 11390401
[TBL] [Abstract][Full Text] [Related]
11. V(D)J recombinase-like activity mediates hprt gene deletion in human fetal T-lymphocytes.
Fuscoe JC; Zimmerman LJ; Lippert MJ; Nicklas JA; O'Neill JP; Albertini RJ
Cancer Res; 1991 Nov; 51(21):6001-5. PubMed ID: 1933863
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneous breakpoints on the immunoglobulin genes are involved in fusion with the 5' region of BCL2 in B-cell tumors.
Yonetani N; Ueda C; Akasaka T; Nishikori M; Uchiyama T; Ohno H
Jpn J Cancer Res; 2001 Sep; 92(9):933-40. PubMed ID: 11572760
[TBL] [Abstract][Full Text] [Related]
13. Disruption of the multiple tumor suppressor gene MTS1/p16(INK4a)/CDKN2 by illegitimate V(D)J recombinase activity in T-cell acute lymphoblastic leukemias.
Cayuela JM; Gardie B; Sigaux F
Blood; 1997 Nov; 90(9):3720-6. PubMed ID: 9345058
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous Quantification of t(14;18) and HPRT Exon 2/3 Deletions in Human Lymphocytes.
Fuscoe JC
Methods Mol Biol; 2020; 2102():361-370. PubMed ID: 31989567
[TBL] [Abstract][Full Text] [Related]
15. Prevalent involvement of illegitimate V(D)J recombination in chromosome 9p21 deletions in lymphoid leukemia.
Kitagawa Y; Inoue K; Sasaki S; Hayashi Y; Matsuo Y; Lieber MR; Mizoguchi H; Yokota J; Kohno T
J Biol Chem; 2002 Nov; 277(48):46289-97. PubMed ID: 12228235
[TBL] [Abstract][Full Text] [Related]
16. Analysis of mutagenic V(D)J recombinase mediated mutations at the HPRT locus as an in vivo model for studying rearrangements with leukemogenic potential in children.
Finette BA
DNA Repair (Amst); 2006 Sep; 5(9-10):1049-64. PubMed ID: 16807138
[TBL] [Abstract][Full Text] [Related]
17. A role for secondary V(D)J recombination in oncogenic chromosomal translocations?
Davila M; Foster S; Kelsoe G; Yang K
Adv Cancer Res; 2001; 81():61-92. PubMed ID: 11430596
[TBL] [Abstract][Full Text] [Related]
18. V(D)J recombinase mediated inter-chromosomal HPRT alterations at cryptic recombination signal sequences in peripheral human T cells.
Messier TL; O'Neill JP; Finette BA
Hum Mutat; 2006 Aug; 27(8):829. PubMed ID: 16835902
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous quantification of t(14;18) and HPRT exon 2/3 deletions in human lymphocytes.
Fuscoe JC
Methods Mol Biol; 2005; 291():171-8. PubMed ID: 15502222
[TBL] [Abstract][Full Text] [Related]
20. The t(8; 14) chromosomal translocation occurring in B-cell malignancies results from mistakes in V-D-J joining.
Haluska FG; Finver S; Tsujimoto Y; Croce CM
Nature; 1986 Nov 13-19; 324(6093):158-61. PubMed ID: 3097550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
